PYR101 Episode 7

Open Access and ACS AuthorChoice

acs-resources

“The introduction to SciFinder was really interesting. I had no idea about it. I will start using that now." 

Elisabeth Krizek, Graduate Student
University College London, United Kingdom

Publishing Your Research 101

Episode 7 – Open Access and ACS AuthorChoice

About the Episode

The seventh episode focuses on open access for journal articles and the ACS AuthorChoice program featuring Larry Marnett, the Editor-in-Chief of Chemical Research in Toxicology. Dr. Marnett was an early proponent among ACS editors for open access, a publishing model in which an article is available to all users without regard to subscription. The first fully open access article published in any ACS journal was one of his 2006 articles. There are various economic models across scientific publishing for enabling open access; the ACS AuthorChoice program is the option available within ACS Publications. The program allows an author to pay an open access fee (a basic fee with discounts for subscribing institutions and ACS members) to make his/her article openly available upon publication. This allows the author to fulfill funding agency requirements or to make a personal choice on open access. Marnett discusses open access, why he selects the ACS AuthorChoice option when publishing in ACS journals, and notes that selecting the AuthorChoice option has no impact on whether an article will be accepted for publication.

Related Resources

About The Author

Lawrence J. Marnett

Professor of Cancer Research, Vanderbilt University School of Medicine

Lawrence J. Marnett is the founding and current Editor-in-Chief of Chemical Research in Toxicology. He is the Mary Geddes Stahlman Professor of Cancer Research, Vanderbilt University School of Medicine, and Director of the Vanderbilt Institute of Chemical Biology. He received his B.S. degree from Rockhurst College and his Ph.D. in chemistry from Duke University. His research interests include enzyme cyclooxygenase-2 in cancer and inflammation as well as on the contribution of normal metabolism to the generation of DNA damage and mutation. He is author of more than 380 research publications and 10 patents. Learn more